Search Grant Opportunities

DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

ID: HT942526LCRPPCOSA • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:
Loading

Description

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.

Distinctive Features:

This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.

This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.

Background
The FY26 Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) is administered by the Defense Health Agency (DHA). It aims to promote evidence-based, patient-centered approaches to improve health outcomes related to lung cancer. The program seeks to enhance the patient experience in defined populations by addressing critical gaps in cancer research, care, and patient outcomes. The LCRP was initiated by Congress in 2009 to support innovative research focused on lung cancer management and treatment.

Grant Details
The PCOSA supports high-risk, high-reward research studies that span survivorship, health outcomes, and comparative effectiveness research. Proposed projects may include translational or clinical research, including pilot clinical trials. Key elements include:
- Inclusion of a lung cancer patient/survivor or caregiver as an advocate in the research team.
- Research must address at least one of the FY26 LCRP Areas of Emphasis related to health outcomes and survivorship.
- Studies may focus on quality of life, symptom management, psychological health, and the impact of comorbidities on survivorship care.
- The maximum funding amount is $975,000 per award with a total funding pool of approximately $1.95 million for about two applications.

Eligibility Requirements
Eligible applicants include extramural and intramural U.S. Department of War organizations, both foreign and domestic, for-profit and nonprofit entities. Principal Investigators must be independent investigators affiliated with an eligible organization regardless of ethnicity or nationality. Each investigator can only be named as PI on one application for this award.

Period of Performance
The maximum period of performance for funded projects is three years.

Grant Value
The total value allocated for this grant opportunity is approximately $1.95 million, with individual awards capped at $975,000.

Place of Performance
The specific geographic locations for performing the grant activities are expected to be within the United States.

Overview

Category of Funding
Science and Technology and other Research and Development
Funding Instruments
Grant
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 5/5/26 U.S. Army Medical Research Acquisition Activity posted grant opportunity HT942526LCRPPCOSA for DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award with funding of $2.0 million. The grant will be issued under grant program 12.420 Military Medical Research and Development. It is expected that 2 total grants will be made.

Timing

Posted Date
May 5, 2026, 12:00 a.m. EDT
Closing Date
Sept. 2, 2026, 12:00 a.m. EDT Due in 94 Days
Last Updated
May 6, 2026, 1:51 p.m. EDT
Version
2
Archive Date
Oct. 2, 2026

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$1,950,000
Estimated Number of Grants
2

Contacts

Contact
Danielle Reckley Grantor
Contact Email
Email Description
eBRAP Help Desk
Contact Phone
(301) 619-1139

Documents

Posted documents for HT942526LCRPPCOSA

Opportunity Assistant


AI Analysis

AI Generate

Potential Applicants and Partners

Awardees that have recently won grants similar to HT942526LCRPPCOSA

Incumbent or Similar Grants

Grants similar to HT942526LCRPPCOSA

Similar Active Opportunities

Open grant opportunities similar to HT942526LCRPPCOSA

Experts for DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

Recommended subject matter experts available for hire